These illustrations show the breadth of our experience and ability and our knowledge of how to achieve the best result for our clients in a cost-effective manner.
Case Study 1.
A leading US injectable company struggled with the huge patent landscape for its barrel lubrication process. The opinion they obtained from the reputed law firm was non-conclusive. We identified the key patents to design around which helped the client to finalize the process in a cost-effective manner.
Case Study 2.
Our client wanted to develop a US-ANDA, we studied the existing patent landscape, and critical points in ongoing litigation and helped the client in planning well for the earliest dismissal of the litigation proceedings.
Case Study 3.
Our client, a leader in reproductive medicine and maternal health, asked us to identify white space in the therapeutic area of interest, for developing differentiated products. We screened the landscape and identified several opportunities which they could take to KOLs to finalize.
Case Study 4.
Our client which has a range of biological, biotech, and pharmaceutical products in the Indian & global market approached us to look at their patent portfolio. We screened the patent portfolio considering the market changes, business interest, business value, strength of the patent, enforcement possibility, and the purpose that application/patent serves & the value it brings. The client could save not only the money being spent on prosecution & maintenance but also identify the patents which are enforceable.
Case Study 5.
One of our European clients which manufacture, and markets generic pharmaceutical products for direct selling and dossier out-licensing, approached us for one of its products, which was under development for several years. Our in-depth analysis of the patent landscape and ongoing litigation gave them an insight into their position as a late entrant in the market, so they decided to drop the product. Since then, we are consulted for IP strategy confirmation on all the key products under development.
Case Study 6.
One of the European pharma start-ups which work across dosage forms, therapeutic areas, and market channels, hired us as their IP partners, we are not just conducting the freedom to operate analysis but also helping them track the ongoing proceedings at EPO & European Courts on critical patents/applications. So that they can prioritize the portfolio based on early entry possibility. In a short period, they have launched multiple products and we are proud to be part of their exciting journey.
Case Study 7.
A US company run by professional clinicians, industry veterans & product development experts, works on identifying novel therapeutics/products. We helped them protect one of their products by drafting a patent application for filing at USPTO.
Case Study 8.
One of the clients having the US & Europe as key geographies of business interest approached us to identify long-term injectables with a possible entry in a specified period. After understanding their capabilities, and infrastructure, we screened the products, patent landscapes, and ongoing proceedings, and identified a few opportunities for ANDA filing in US & Europe.
Case Study 9.
A fully integrated pharmaceutical company with an established presence across the globe, involved in the CMO & CDMO business of pharmaceutical preparations in various dosage forms catering to diverse therapeutic categories approached us for patent landscape, FTO, and advice on design around one of their products.
Now we are handling their entire development pipeline, also supporting them in extending their products to the UK, Europe, Australia & New Zealand.
Case Study 10.
A fast-growing pharmaceutical company focused on providing innovative product solutions to the global market, approached us for patent infringement and validity dispute concerning our client’s innovative & best-selling product. We advised them on how to commence proceedings against the alleged infringer.
Case Study 11.
Advised one of the API manufacturing companies on Patent V. Trade secret for their process for one of the key APIs. Helped them choose the right approach.
Case Study 12.
One of the big US law firms approached us for the Identification of Para-IV position on a few products for their client. The products had multiple OB patents listed, including the purity, composition & MoU patents. Based on our analysis, the client could secure the First-to-File position on these products.
Case Study 13.
One of the investor start-up companies approached us for due diligence on a few ANDA projects for acquisition. With our in-depth patent landscape and ongoing litigation analysis, they could understand the prospective client’s strategy and decide on acquisition/investment concerning the products.